Package 51407-866-60

{"route": ["ORAL"], "spl_id": "3c301c61-8245-0ad5-e063-6294a90a7b71", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["205328"], "spl_set_id": ["3c30216d-f9f5-104b-e063-6294a90af8fd"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (51407-866-60)", "package_ndc": "51407-866-60", "marketing_start_date": "20250609"}], "brand_name": "Lamivudine", "product_id": "51407-866_3c301c61-8245-0ad5-e063-6294a90a7b71", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "51407-866", "generic_name": "Lamivudine", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "100 mg/1"}], "application_number": "ANDA202941", "marketing_category": "ANDA", "marketing_start_date": "20140102", "listing_expiration_date": "20261231"}